Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Sep 11;15(17):7137-53.
doi: 10.1093/nar/15.17.7137.

Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction

Affiliations
Free PMC article

Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction

D R Hurwitz et al. Nucleic Acids Res. .
Free PMC article

Abstract

We have compared several combinations of enhancers and promoters in expressing the chloramphenicol acetyl transferase gene in transient assays, in mouse C127, the most widely used host cell for the bovine papilloma virus (BPV) expression vector. Of the various combinations tested, the unit comprised of the SV40 enhancer and adenovirus type 2 major late promoter (MLP) was the most active in BPV transformed C127 cells. We further demonstrate that untransformed and BPV transformed C127 cells respond differently to the various enhancer/promoter combinations tested. Moving the SV40 enhancer closer to the cap site of a complete MLP (from -414 to -107) reduced potentiation to less than half in BPV transformed cells. The level of potentiation with enhancer at either site was similar in human HeLa cells. In BPV transformed C127 cells, the SV40 enhancer and the MLP (at the -414 site) supports 4-5 fold greater levels of expression than the murine sarcoma virus (MSV) enhancer/mouse metallothionein (MT) promoter which has previously been extremely effective in BPV vectors. Our findings provide a basis for the improvement of the BPV vector system in supporting increased levels of expression of proteins of important therapeutic application.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4040-4 - PubMed
    1. Mol Cell Biol. 1981 Jun;1(6):486-96 - PubMed
    1. Cell. 1983 Jul;33(3):729-40 - PubMed
    1. Mol Cell Biol. 1983 Jun;3(6):1032-9 - PubMed
    1. Cell. 1983 Oct;34(3):865-79 - PubMed

Substances